Article... IEEE International Conference on Computer Vision workshops. IEEE International Conference on Computer Vision2025
Multi-Modal Deep Clustering Survival Machines for Alzheimer's Disease Subtype Discovery.
Article in ... IEEE International Conference on Computer Vision workshops. IEEE International Conference on Computer Vision, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Staging and Pseudotime Inference of Alzheimer's Disease Progression using Multimodal Imaging Data.Proceedings. IEEE International Conference on Healthcare Informatics · 2026Article
- Expert-Driven Survival Machines: Improving Stratification and Interpretability in Multiple Clinical Cohorts.ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Survival clustering approaches estimate time-to-event prediction and clustering simultaneously. Current methods, however, are often limited by their reliance on single data modalities and their separation of risk prediction from patient subtyping. This creates a pressing need for a unified framework that can simultaneously discover patient subgroups and predict their conversion risk by integrating diverse biomarker data. Here, we introduce Multi-Modal Deep Clustering Survival Machines (MMDCSM), a unified framework that (1) encodes each modality via modality-specific MultiLayer Perceptrons (MLPs), (2) fuses embeddings into a joint representation, and (3) models survival outcomes through a mixture of Weibull expert distributions whose soft assignments simultaneously define patient subtypes and individualized survival curves. Applied to a cohort of 382 Mild Cognitive Impairment (MCI) patients, MMDCSM significantly outperformed existing methods in identifying distinct low- and high-risk subgroups for Alzheimer's disease (AD) conversion while delivering competitive accuracy in predicting each patient's personalized timeline to progression. Our model also identified key brain regions, including the hippocampus, that were most influential in distinguishing high-risk converters. This approach enables more accurate, early-stage risk stratification, paving the way for targeted interventions designed to delay or prevent disease progression.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.